首页 | 官方网站   微博 | 高级检索  
     

丁咯地尔联合依达拉奉治疗后循环脑梗死的临床分析
引用本文:张舸.丁咯地尔联合依达拉奉治疗后循环脑梗死的临床分析[J].现代保健,2012(19):19-20.
作者姓名:张舸
作者单位:河南科技大学第三附属医院洛阳东方医院,河南洛阳471003
摘    要:目的:观察丁咯地尔联合依达拉奉治疗后循环脑梗死的疗效。方法:将70例后循环脑梗死患者随机分为试验组(35例)及对照组(35例),两组均给予拜阿司匹林、阿托伐他汀钙片治疗,治疗组在此基础上给予丁咯地尔联合依达拉奉注射液静脉滴注,10d为1个疗程。结果:试验组神经功能缺损评分在第5天、10天明显低于对照组俨〈0.05)。结论:丁咯地尔联合依达拉奉治疗后循环脑梗死疗效显著。

关 键 词:丁咯地尔  依达拉奉  脑梗死

Study on the Efficacy of Buflomedil Combined with Edaravone on Posterior Circulation Cerebral Infarction
Authors:ZHANG Ge
Affiliation:ZHANG Ge. (First-author's address : Luoyang Dongfang Hospital, the Third Affiliated Hospital of Henan University of Science and Technology, Luoyang 471003, China)
Abstract:Objective: To observe the efficacy of buflomedil combined with edaravone on posterior circulation cerebral infarction. Method:70 cases of posterior circulation cerebral infarction patients were randomly divided into experimental group (35 cases) and control group (35 cases). Two groups were both given aspirin, atorvastatin calcium tablets, and experimental group was additionally given buflomedil injection combined with edaravone injection for 10 days.Result: Neurological deficit score of experimental group at 5 days, 10 clays was significantly lower than that of control group (P〈0.05). Conclusion: The efficacy of buflomedil combined with edaravone on posterior circulation cerebral infarction is remarkable.
Keywords:Buflomedil  Edaravone  Cerebral Infarction
本文献已被 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司    京ICP备09084417号-23

京公网安备 11010802026262号